Anticancer Therapy Targeting Telomeres And Telomerase
Anticancer Therapy Targeting Telomeres and Telomerase Current Status cancer cells cope with this by upregulating the active form of telomerase. the Artemis-related nuclease, Apollo,[4,5] and possibly also ... Fetch Document
SF424(R&R) Biographical Sketch Format Page
Rational, biology-based combination therapy for the treatment of ovarian cancer: Targeting XPA . The goal of this pilot project is to develop small molecule inhibitors of the xeroderma pigmentosum group A Targeting the ERCC1/XPF nuclease for cancer therapy . ... Get Content Here
Nucleotide Excision Repair Inhibitors: Still A Long Way To Go
The ERCC1-XPF nuclease was not recruited to the damaged DNA sites after ex druggable targets and no one in the past thought of regulating NER as a way to improve cancer therapy. Nucleotide Excision Repair Inhibitors: Still a Long Way to Go http://dx.doi.org/10.5772/46014 577. ... Doc Retrieval
Scientific Program 11-11-2014 (final Program Formatted)
Scientific Program . Organizing Committee Organizers Alan Tomkinson University of New Mexico, USA Vilhelm A. Bohr National Institute on Aging, USA Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA 11:50 DNA damage recognition and signaling ... Retrieve Full Source
CURRICULUM VITAE John J. Turchi - Indiana University
CURRICULUM VITAE John J. Turchi . PRESENT ADDRESS: Targeting the ERCC1/XPF nuclease for cancer therapy . Project Period: 09/26/2012 Annual conference of targeted lung cancer therapy ISLAC, Targeting NER in cancer Chemotherapy, 2007 Santa Monica CA . Lehman, ... Fetch Full Source
Structure, Vol. 13, 1849–1858, December, 2005, ª2005 Elsevier ...
Teins responsible for ERCC1/XPF complex formation. Both domains exhibit the double helix-hairpin-helix we propose a model for the targeting of XPF nuclease via ERCC1-mediated interactions in an extreme risk of UV-induced skin cancer and many features of accelerated ageing, respectively ... Document Retrieval
No comments:
Post a Comment